About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2021
2020
2019
2018
2017
2016
25
Feb
2021
15:29 E.S.T.
Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
Read more
16
Feb
2021
01:00 E.S.T.
Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
Read more
15
Dec
2020
19:18 E.S.T.
Cellectis Announces Withdrawal of Follow-On Offering
Read more
14
Dec
2020
15:48 E.S.T.
Cellectis Announces Launch of Follow-On Offering
Read more
05
Dec
2020
17:00 E.S.T.
Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting
Read more
17
Nov
2020
18:58 E.S.T.
FDA Lifts Clinical Hold on MELANI-01 Study Evaluating Cellectis’ Product Candidate UCARTCS1 in Multiple Myeloma
Read more
16
Nov
2020
16:30 E.S.T.
Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer
Read more
05
Nov
2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Read more
04
Nov
2020
00:00 E.S.T.
American Society of Hematology (ASH) Abstract Shows Initial Anti-Leukemic Activity of UCART22 in BALLI-01 Phase 1 Study in R/R Adult B-ALL
Read more
21
Oct
2020
16:30 E.S.T.
Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST
Read more
1
2
3
Next